/Companies

Toposbio

San Francisco, US · Founded 2024 · 2 known investors

Find your way into Toposbio

Sign up to see every warm intro you have to Toposbio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Toposbio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Topos Bio develops an AI-native drug discovery platform focused on intrinsically disordered proteins, which are dynamic proteins associated with diseases such as Alzheimer's and prostate cancer. Its approach models protein ensembles instead of single static structures to target proteins previously considered undruggable.

Founders & leadership

Toposbio was founded in 2024 by Ryan Zarcone and Amir Khosrowshahi.

RZRyan Zarcone
Ryan ZarconeCo-Founder and CEO
AKAmir Khosrowshahi
Amir KhosrowshahiCo-Founder and CTO

Board

ECEllen Chisa
Ellen ChisaBoard DirectorPartner at boldstart ventures

Investors · 2

Reported raises · per SEC filings

Form D private placements

$9M disclosed across 1 round · 2024

▶$9MraisedJan 2025 · 2 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Amir KhosrowshahiExecutive Officer, Director, Promoter
  • Ellen ChisaDirector
  • Ryan ZarconeExecutive Officer, Director, Promoter
Offering amount
$10.5M
Amount sold
$9M
First sale
Dec 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Toposbio do?
Topos Bio develops an AI-native drug discovery platform focused on intrinsically disordered proteins, which are dynamic proteins associated with diseases such as Alzheimer's and prostate cancer. Its approach models protein ensembles instead of single static structures to target proteins previously considered undruggable.
Who founded Toposbio?
Toposbio was founded by Ryan Zarcone, Amir Khosrowshahi in 2024.
Who are Toposbio's investors?
Toposbio's investors include boldstart ventures, Threshold Ventures.
How much funding has Toposbio raised?
Toposbio has disclosed $9M raised across 1 round.
Where is Toposbio headquartered?
Toposbio is headquartered in San Francisco, US.